Eva Martínez-de-Castro

7PUBLICATIONS
100CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 30, 2026
Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial.

|Nov 18, 2025
Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.

Mercedes Salgado, Juan de la Camara-Gómez, Ignacio García-Escobar

|Aug 09, 2025
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry.

Carlos López-López, Eva Martínez de Castro, Ana Fernández Montes

|May 19, 2025
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Maria Alsina, Guillermo Villacampa, Carlos de Andrea

|Dec 14, 2024
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.

Javier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado

|May 09, 2023
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study.

Manuel Sánchez-Cánovas, Paula Jimenez-Fonseca, David Fernández Garay

Pageof 2

Frequent Collaborators

2 joint publications

Andrés Muñoz

2 joint publications

Paula Jimenez-Fonseca

2 joint publications

Javier Sastre

2 joint publications

Míriam Lobo-de-Mena